1 Radioligand binding and patch-clamp techniques were used to study the actions of g-aminobutyric acid (GABA) and the general anaesthetics propofol (2,6-diisopropylphenol), pentobarbitone and 5a-pregnan3a-ol-20-one on rat a1 and b3 GABA A receptor subunits, expressed either alone or in combination. . However, the binding was not in¯uenced by GABA (10 nM ± 100 mM). Neither GABA (100 mM) nor picrotoxin (10 mM) aected currents recorded from cells expressing b3 cDNA, suggesting that b3 subunits do not form functional GABA A receptors or spontaneously active ion channels. 4 GABA (10 nM ± 100 mM) modulated [ 35 S]-TBPS binding to the membranes of cells transfected with both a1 and b3 cDNAs. GABA (0.1 mM ± 1 mM) also dose-dependently activated inward currents with an EC 50 of 9 mM recorded from cells transfected with a1 and b3 cDNAs, clamped at 760 mV. 5 Propofol (10 nM ± 100 mM), pentobarbitone (10 nM ± 100 mM) and 5a-pregnan-3a-ol-20-one (1 nM ± 30 mM) modulated [ 35 S]-TBPS binding to the membranes of cells expressing either a1b3 or b3 receptors. Propofol (100 mM), pentobarbitone (1 mM) and 5a-pregnan-3a-ol-20-one (10 mM) also activated currents recorded from cells expressing a1b3 receptors. 6 Propofol (1 mM ± 1 mM) and pentobarbitone (1 mM) both activated currents recorded from cells expressing b3 homomers. In contrast, application of 5a-pregnan-3a-ol-20-one (10 mM) failed to activate detectable currents. 7 Propofol (100 mM)-activated currents recorded from cells expressing either a1b3 or b3 receptors reversed at the C1 7 equilibrium potential and were inhibited to 34+13% and 39+10% of control, respectively, by picrotoxin (10 mM). 5a-Pregnan-3a-ol-20-one (100 nM) enhanced propofol (100 mM)-evoked currents mediated by a1b3 receptors to 1101+299% of control. In contrast, even at high concentration 5a-pregnan-3a-ol-20-one (10 mM) caused only a modest facilitation (to 128+12% of control) of propofol (100 mM)-evoked currents mediated by b3 homomers. 8 Propofol (3 ± 100 mM) activated a1b3 and b3 receptors in a concentration-dependent manner. For both receptor combinations, higher concentrations of propofol (300 mM and 1 mM) caused a decline in current amplitude. This inhibition of receptor function reversed rapidly during washout resulting in à surge' current on cessation of propofol (300 mM and 1 mM) application. Surge currents were also evident following pentobarbitone (1 mM) application to cells expressing either receptor combination. By contrast, this phenomenon was not apparent following applications of 5a-pregnan-3a-ol-20-one (10 mM) to cells expressing a1b3 receptors. 9 These observations demonstrate that rat b3 subunits form homomeric receptors that are not spontaneously active, are insensitive to GABA and can be activated by some general anaesthetics. Taken together, these data also suggest similar sites on GABA A receptors for propofol and barbiturates, and a separate site for the anaesthetic steroids.
Introduction
At clinically relevant concentrations most intravenous general anaesthetics (IVGAs) including propofol, etomidate, propanidid and the anaesthetic barbiturates and steriods modulate GABA A receptors (Franks & Lieb, 1994; Hales & Olsen, 1994) . GABA A receptor modulation by propofol and pentobarbitone has three components: (1) at low concentrations both agents potentiate g-aminobutyric acid (GABA)-evoked responses; (2) at higher concentrations, in the absence of GABA, they directly activate GABA A receptors; (3) at even higher concentrations propofol and pentobarbitone inhibit receptor function (Peters et al., 1989; Robertson, 1989; Hara et al., 1993; Orser et al., 1994; Adora & Hales, 1995) . Anxiolytic and anticonvulsant benzodiazepines do not directly activate GABA A receptors but, like IVGAs, the benzodiazepines potentiate GABA-evoked respones (Hales & Olsen, 1994) .
By analogy with the nicotinic acetylcholine receptor, the GABA A receptor is postulated to have a pentameric structure (Burt & Kamatchi, 1991) . To date, 17 subunit types have been cloned from mammalian sources (a1-6, b1-3, g1, g2S, g2L, g3, d, r1,2 and 3), thus providing numerous possible combinations with the potential for dierent pharmacological pro®les (Burt & Kamatchi, 1991; Ogurusu & Shingai, 1996) . The benzodiazepines require the presence of a and g subunits for their modulation of GABA A receptors (Pritchett et al., 1989) . By contrast, modulation of GABA A receptors by IVGAs does not appear to show an`all-or-none' dependence on speci®c subunits (Shingai et al., 1991; Horne et al., 1993; Jones et al., 1995) . However, there is evidence for an in¯uence of receptor subunit combination on the ecacy of IVGAs, relative to GABA, as GABA A receptor-activators (Jones et al., 1995; Sanna et al., 1995; Krishek et al., 1996; Cestari et al., 1996) .
GABA A receptor modulation can be investigated by use of radioligand binding and electrophysiological assays. However, comparisons between binding and electrophysiological data are complicated by the markedly dierent time courses of the two experimental approaches. IVGAs enhance [ 3 H]-muscimol binding to membranes containing GABA A receptors and this corresponds to their ability to enhance GABA-activated currents recorded from cells expressing receptors (Hales & Olsen, 1994; Peters et al., 1988; Turner et al., 1989) . Additionally, the IVGAs also modulate the binding of the convulsant ligand [ 35 S]-TBPS to GABA A receptors (Concas et al., 1994; Hawkinson et al., 1994; Slany et al., 1995) . This action may in part correspond to the ability of these agents to activate receptors directly and evoke Cl 7 currents in the absence of GABA.
By transiently transfecting immortalized human embryonic kidney cells with a1 and b3 cDNAs, either alone or in combination, we have investigated the ability of GABA, propofol, pentobarbitone and 5a-pregnan-3a-ol-20-one to activate recombinant GABA A receptors. Previous studies suggest that only certain homomeric GABA receptors form functional ion channels. These include the r (Shimada et al., 1992) and b subunits (Sigel et al., 1989; Sanna et al., 1995; Krishek et al., 1996; Cestari et al., 1996) . Most homomeric b receptors show spontaneous channel openings that are enhanced by some IVGAs (Sanna et al., 1995; Krishek et al., 1996; Cestari et al., 1996) . Whether these compounds directly activate homomeric b receptors or potentiate spontaneous channel activity remains undetermined. In addition, spontaneously active b homomers of some species are insensitive to GABA Cestari et al., 1996) . It is unclear whether this lack of sensitivity is due to the absence of GABA recognition or to the receptor being already active. We investigated whether rat b3 subunits form homomeric receptors that bind The plot of the current amplitude against holding potential (from the recordings illustrated in (a)) shows that GABA-evoked currents exhibit outward recti®cation and in this case reversed at approximately 7 mV. On average, GABAevoked currents reversed at 0.5+2.8 mV (n=4), close to the theoretical Cl 7 equilibrium potential with the solutions described in the Methods section. The curve was ®tted to the data points by an exponential function. (c) Currents activated by increasing concentrations of GABA recorded from an HEK293 cell expressing a1b3 receptors. (d) A plot of the concentration-response relationship for GABA-activated currents. Data points represent the mean of at least four determinations and the vertical lines represent s.e.mean. From the logistic ®t (Adora & Hales, 1995) to the data points, GABA activated currents with an EC 50 of 9.1+1.2 mM and a Hill slope of 0.84+0.07. (n=6) A summary of the compounds tested that do or do not activate a1b3 and b3 receptors including mean current amplitudes. GABA (100 mM), 5a-pregnan-3a-ol-20-one (10 mM), propofol (100 mM) and pentobarbitone (1 mM) were pressure-applied to individual cells. Values represent the number of cells which responded out of the total number tested.
Methods

Cell cultures
Transfection
Cells were transfected with plasmids (pCDM8) containing cDNAs for rat a1 and b3 GABA A receptor subunits, either alone or in combination, by the calcium phosphate precipitation method. Complete open reading frames, encoding the rat GABA A receptor a1 (Khrestchatisky et al., 1989) and b3 (Lolait et al., 1989) subunits were subcloned into the pCDM8 vector (Invitrogen, San Diego, CA). Plasmid(s) containing cDNA for the GABA A receptor subunits (10 mg) were added to a solution contained double distilled H 2 O, CaCl 2 (2.5 M) and HEPES buer at a volumetric ration of 9:1:10. HEPES buer contained (in mM): NaCl 280, Na 2 HPO 4 1.5, HEPES 50 (pH 7.10). The solution formed a light precipitate (10 min, 228C) and was then added to cultures (0.1 ml solution to 1 ml of growth medium). Cells were incubated (5% CO 2 , 95% air, at 378C) for 24 h, washed and incubated for a further 48 ± 72h before experimentation.
[
S]-TBPS binding experiments
Transfected cells were washed twice with phosphate-buered saline and harvested by scraping into an ice-cold TEN solution comprised of (in mM): Tris-HCl 10, EDTA 1, NaCl 100 (pH 7.5). The cells were collected by centrifugation (5000 g, 10 min), hand-homogenized in TEN, and a crude membrane fraction was obtained by centrifugation (30,000 g, 30 min). NaCl (pH 7.5). Non-speci®c binding was determined in the presence of 100 mM picrotoxinin, and was equal to the binding of mock-transfected cell membranes (50.03 pmol mg 71 protein). Following incubation, 5 ml of ice-cold buer (20 mM Tris-HCl, 1 M NaCl; pH 7.5) was added, and the membranes ®ltered through Whatman GF/C ®lters. The ®lters were washed twice with 5 ml of the same buer before scintillation counting. Binding data are expressed as the mean+s.d.
Electrophysiology
The patch-clamp technique was used to record whole-cell currents from HEK293 cells voltage-clamped at 760 mV (unless otherwise stated). The recording chamber was perfused (5 ml min
71
) with an extracellular solution consisting of (in mM): NaCl 140, KCl 4.7, MgCl 2 1.2, CaCl 2 2.5, glucose 11 and HEPES 10 (pH 7.4). The electrode solution contained (in mM): KCl 140, MgCl 2 2.0, EGTA 11 and HEPES 10 (pH 7.4). In several experiments examining b3 homomers Mg-ATP (3 mM) was included in the electrode solution in an attempt to minimize current run-down. Membrane currents were monitored by an Axopatch-200A (Axon Instruments Inc.) patch-clamp ampli®er. Currents were low-pass ®ltered at a cuto frequency of 2 KHz (Bessel characteristics), digitized with a digital audio processor (Sony PCM-501ES) and recorded onto VCR tapes for subsequent analysis. Currents were simultaneously recorded (Gould 2200) onto chart paper.
In experiments examining activation of GABA A receptors, GABA and anaesthetics were applied locally by pressure ejection (General Valve Picospritzer II) at a pressure of 70 kPa, from glass micropipettes positioned approximately 50 mm from the cell under investigation. To minimize GABA A receptor desensitization cells were continuously superfused with recording solution. In dose-response experiments randomized doses of GABA or propofol were applied via dierent pipettes with similar resistances (2.7+0.2 MO) positioned, with the aid of an eye piece graticule, in the same location (Adodra & Hales, 1995) . During concentration-response experiments agonists were applied for 1 s in order to achieve equilibrium concentrations. It is possible that dilution may occur at some receptor sites, therefore concentrations represent maximum estimates of true agonist concentrations. A period of at least 4 min wash was allowed between each application to prevent desensitization. All other drugs were bath applied, as were the anaesthetics in experiments investigating their GABA-potentiating eects. For modulation experiments, in which antagonists or anaesthetics were bath applied, GABA (100 mM) was applied brie¯y at a duration (5 ± 30 ms) that activated 510% of the maximum GABA (100 mM)-evoked current amplitude.
Concentration-response relationships were ®tted with the logistic equation as previously described (Adodra & Hales, 1995) . Consistent with previous studies (Bormann et al., 1987; Peters et al., 1989; Robertson, 1989; Hales & Lambert, 1991; Adodra & Hales, 1995) , GABA A -receptor-mediated currentvoltage relationships displayed outward recti®cation and were well ®tted with an exponential function (Bormann et al., 1987) . All electrophysiology data are expressed as the arithmetic mean+s.e.mean.
Drugs and reagents used
The Figure 1a ). Low concentrations of GABA (10 nM ± 1 mM) enhanced binding, whereas higher concentrations (10 ± 100 mM) had an inhibitory eect. In contrast, the TBPS binding site of b3 receptors was insensitive to GABA. A lack of high-anity GABA-binding sites on b3 receptors was con®rmed by their inability to bind [ 3 H]-muscimol (1 ± 500 nM; results not shown). In common with GABA, propofol, pentobarbitone and the anaesthetic steroid 5a-pregnan-3a-ol-20-one modulated [ 35 S]-TBPS binding to a1b3 receptors (Figure 1) . However, unlike GABA, the anaesthetics also displaced the ligand from membranes containing only b3 subunits. 5a-Pregnan-3b-ol-20-one (0.1 ± 10 mM), a stereoisomer of 5a-pregnan-3a-ol-20-one which lacks anaesthetic activity, did not signi®cantly aect ligand binding to either a1b3 or b3 receptors (results not shown).
Activation of recombination GABA A receptors by GABA potential of 760 mV (n=54). In order to establish the currentvoltage relationship of the GABA-elicited currents of the a1b3 receptor, cells were held at potentials from 760 to 60 mV. With intracellular and extracellular Cl 7 concentrations of 144 mM and 152 mM, respectively, the GABA-elicited currents reversed at 0.5+2.8 mV (n=4), close to the theoretical Cl 7 equilibrium potential under these recording conditions ( Figure  2a, b) . Currents were larger at positive potentials compared to their amplitudes at corresponding negative potentials indicative of outward recti®cation. The outward recti®cation seen in the present study constrasts with the linear currentvoltage relationship observed by Valeyev et al. (1993) under similar ionic conditions.
The amplitude of GABA-activated currents, recorded from cells clamped at 760 mV, increased with increasing concentrations of GABA (0.1 mM ± 1 mM) applied for a duration of 1 s (Figure 2c) . By ®tting the concentration-response data with a curve described by the logistic equation (Adodra & Hales, 1995) the Hill coecient and EC 50 were calculated to be 0.84 and 9.1 mM, respectively. This concentration-response relationship is similar to that from a previous study of the actions of GABA on recombinant a1b3 receptors (Valeyev et al., 1993) . GABA (100 mM) application to control HEK293 cells (n=10) and cells transfected with a1 (n=6) or b3 (n=13) subunit cDNAs alone failed to activate discernible currents (Table 1) .
Pharmacological properties of a1b3 GABA A receptors
GABA A receptors can be identi®ed on the basis of their sensitivity to the selective inhibitors bicuculline and picrotoxin. GABA (100 mM)-evoked currents recorded from HEK293 cells expressing a1b3 GABA A receptors were inhibited to 16+9% (n=5) of their control amplitude by bath applied bicuculline methiodide (10 mM) (Figure 3a) , the inhibition was reversed on washout of the antagonist. GABA-evoked currents were also reversibly inhibited to 28+6% (n=5) of control by superfusion of picrotoxin (10 mM) (Figure 3b ).
Many compounds with central depressant activity including propofol (Hales & Lambert, 1991) , the anaesthetic barbiturate pentobarbitone (Schulz & Macdonald, 1981) and the anaesthetic steroid 5a-pregnan-3a-ol-one (Majewska et al., 1986) substantially enhance GABA-evoked responses recorded from neurones. Currents activated by brief GABA application to HEK293 cells expressing a1b3 receptors were potentiated by bath applied propofol and 5a-pregnan-3a-ol-20-one ( Figure  3c propofol (3 mM) and 5a-pregnan-3a-ol-20-one (100 nM) were 549+157% (n=7) and 206+45% (n=5) of control, respectively.
Activation of a1b3 and b3 receptors by the anaesthetics
In addition to enhancing GABA-activated currents, many general anaesthetics also directly activate GABA A receptors (Schulz & Macdonald, 1981; Hales & Lambert, 1991; Jones et al., 1995) . The ability of propofol, pentobarbitone and 5a-pregnan-3a-ol-20-one to activate a1b3 GABA A receptors was investigated by locally applying these agents in the absence of GABA. Pressure application of propofol (100 mM) elicited inward currents recorded from cells voltage-clamped at 760 mV (n=49). By contrast, untransfected cells did not respond to the anaesthetic (n=5). The reversal potential of the propofol-elicited currents (4 mV, Figure 4a ,b) was similar to that of GABA-activated currents (Figure 2a,b ).
Cells transfected with the a1 cDNA alone failed to respond to propofol (n=6). However, propofol (100 mM) elicited inward currents in cells expressing homomeric b3 GABA A receptors voltage-clamped at 760 mV (n=124). The currentvoltage relationship for propofol-activated currents mediated by the b3 receptor was similar to that of a1b3 receptors; currents exhibited outward recti®cation and reversed at 3.5+2.2 mV (n=4) (Figure 4c,d) .
The amplitude of currents, seen in response to propofol's activation of a1b3 and b3 receptors, increased with increasing concentrations of propofol (3 ± 100 mM) applied for 1 s (Figure 5 ). Currents activated by propofol concentrations greater than 100 mM tended to have a reduced amplitude and were associated with a surge current seen during propofol washout. This phenomenon has been observed in previous studies on cessation of application of high concentrations of propofol to embryonic hippocampal neurones (Orser et al., 1994) and immortalized hypothalamic neurones ( Adodra & Hales, 1995) . It has been suggested that the decline in current amplitude caused by high propofol concentrations is due to hindrance of GABA A receptor function and that the current surge represents reversal of the inhibition (Adodra & Hales, 1995) . Due to the reduced peak current activated by high propofol concentrations no attempt was made to ®t the data points. However, from the graphs of the peak current amplitude obtained in the presence of propofol at each concentration, the EC 50 values for propofol's activation of a1b3 and b3 receptors are estimated to be approximately 40 mM in both cases. This estimate represents a lower limit and is included for comparison of the two concentration-response relationships. Propofol-evoked currents recorded from b3 expressing cells often showed substantial run-down not seen in recordings from cells expressing a1b3 receptors. The current amplitude declined by 50% within 5 min after the initial propofol application. The rate of run-down declined after this period of time, the current after 10 min was approximately 30% of the initial response. Inclusion of ATP (3 mM) in the intracellular solution had no discernible eect on the rate of current decline. All experiments were conducted 10 min after the ®rst propofol application. In order to overcome run-down when investigating the concentration-response relationship for propofol's activation of b3 receptors, each application was bracketed by applications of 100 mM propofol. Current amplitudes were normalized to the mean amplitudes achieved by bracketing the propofol (100 mM) applications.
Bath applied pentobarbitone (100 mM) potentiated GABA-evoked currents recorded from HEK293 cells expressing a1b3 receptors. At a higher concentration, pentobarbitone (1 mM) also activated currents when applied locally to cells expressing either a1b3 (n=4) or b3 (n=7) receptors (Table 1) . Surge currents similar to those seen following propofol applications were also apparent on cessation of pentobarbitone application to cells expressing either receptor type (data not shown). Unlike propofol and pentobarbitone, 5a-pregnan-3a-ol-20-one (10 mM) did not activate discernible currents in HEK293 cells expressing b3 receptors (n=11; Table 1), even in those cells that had previously responded to propofol (n=7). By contrast, 5a-pregnan-3a-ol-20-one (10 mM) activated a1b3 receptors (Table 1) . No reduction in the peak amplitude of currents occurred with high concentrations of the steroid and termination of its application was not associated with a surge current (data not shown). Therefore, unlike propofol and pentobarbitone, 5a-pregnan-3a-ol-20-one neither activates homomeric b3 receptors nor inhibits a1b3 GABA A receptor activity at high concentrations.
Pharmacology of propofol-activated receptors
Superfusion of picrotoxin (10 mM) reversibly inhibited currents evoked by locally applied propofol (100 mM) to 34+13% (n=4) of control in cells expressing a1b3 receptors (Figure 6a ).
Similar to its action on GABA-activated currents recorded from cells containing a1b3 receptors (Figure 3d ), 5a-pregnan3a-ol-20-one (100 nM) enhanced currents activated by brief propofol (100 mM) application to 1101+299% (n=9) of control (Figure 6b ). Picrotoxin (10 mM) also inhibited propofol (100 mM)-evoked currents recorded from cells expressing homomeric b3 receptors to 39+10% (n=7) of control ( Figure  6c ). By contrast to its action on a1b3 receptors (Figures 3d and  6b ), 5a-pregnan-3a-ol-20-one, even at a high concentration (10 mM), caused only a modest enhancement (128+12% of control, n=7) of propofol-activated currents when applied to cells expressing b3 homomers (Figure 6d) .
Interestingly, application of picrotoxin (10 mM) did not cause a change in base-line current in the absence of propofol. Picrotoxin does alter base-line currents in recordings from cells expressing b1 homomers (Sanna et al., 1995. , Krishek et al., 1996; Cestari et al., 1996) . This phenomenon is caused by the blockade of spontaneous channel openings. No spontaneous currents were observed in recordings from a1b3 or b3 expressing cells.
Discussion
There are con¯icting data regarding the subunit requirements for the formation of functional recombinant GABA A receptors in cell lines (Angelotti & Macdonald, 1993; Im et al., 1995) and Xenopus oocytes (Blair et al., 1988; Sigel et al., 1990) . In general, studies performed soon after the initial cloning of GA-BA A receptor subunits suggested that a and b polypeptides, either alone or in combination, form GABA-activated receptors. However, more recent ®ndings suggest that only certain homomeric receptors, in particular those formed by b subunits, are functional (Sanna et al., 1995; Krishek et al., 1996; Cestari et al., 1996) . In the present study we investigated whether a1 and b3 subunits form functional receptors when transiently expressed either alone or in combination in HEK293 cells. We examined whether the homomeric and/or heteromeric receptor combinations bind [
35 S]-TBPS or are activated by GABA and the anaesthetic compounds propofol, pentobarbitone and 5a-pregnan-3a-ol-20-one.
35 S]-TBPS bound to the membranes of HEK293 cells containing either the a1b3 combination or b3 homomers, suggesting that these subunits form receptors. By contrast, the lack of [ 35 S]-TBPS binding to the membranes of cells transfected with a1 cDNA suggests that this subunit alone does not form receptors. In agreement with this, cells transfected with a1 cDNAs do not respond to GABA application. Recent immuno¯uoresence studies examining the cellular distribution of a1 subunits demonstrate that when expressed alone in HEK293 cells, the subunit remains associated with internal membranes. By contrast, when the a1 and b2 subunits are expressed together both can be found in the plasma membrane where they form functional GABA A receptors (Connolly et al., 1996) . Dierential targeting of a1 and b1 subunits also occurs in epithelial cells in which, when expressed alone, these subunits are localized in the basolateral and apical membranes, respectively (Perez-Valazquez & Angelides, 1993) . However, when expressed together both subunits appear in the apical membrane.
It is well established that a1b3 receptors form functional GABA-activated channels (Lolait et al., 1989; Ymer et al., 1989; Valeyev et al., 1993) and this is con®rmed by our observations. These receptors also have binding sites for the anaesthetically active compounds propofol, pentobarbitone and 5a-pregnan-3a-ol-20-one. The IVGAs modulate [
35 S]-TBPS binding to cell membranes containing a1b3 receptors and potentiate whole-cell GABA-evoked currents mediated by these receptors. At higher concentrations all three IVGAs also activate a1b3 receptors.
The b3 subunit, unlike the b2 subunit is able to access the plasma membranes of HEK293 cells even when expressed alone. This is evident from our observations of [ 35 S]-TBPS binding to b3 homomers and from a previous study (Slany et al., 1995) . However, [
35 S]-TBPS binding to membranes containing b3 homomers is insensitive to GABA. In addition, GABA fails to activate Cl 7 currents recorded from cells expressing b3 receptors. These data suggest that b3 homomers are insensitive to GABA. Such an observation could lead to the assumption that b3 homomers are not functional. However, our data and those of Slany et al. (1995) show that propofol, pentobarbitone and anaesthetic steroids displace [ 35 S]-TBPS binding from membranes containing b3 receptors. Furthermore, propofol and pentobarbitone also activate whole-cell currents when applied to cells expressing b3 homomers. These observations demonstrate that in HEK293 cells the b3 subunit alone forms functional receptors that do not respond to GABA, but are activated by some IVGAs. It is possible that HEK293 cells could modify the properties of recombinant GABA A receptors by contributing a protein from their own genome. Perhaps the most obvious candidate would be a GABA A receptor subunit. Indeed, detectable levels of b3 subunit mRNA are present in untransfected HEK293 cells (Kirkness & Fraser, 1993) . It is unlikely that this subunit contributes to the properties of recombinant receptors in these cells because, prior to transfection, they do not respond to propofol or pentobarbitone, and cells transfected with a1 subunits neither respond to GABA nor do they bind either [ 3 H]-muscimol or [ 35 S]-TBPS. The possibility that there is an unidenti®ed protein interacting with the recombinant receptors cannot be ruled out. However, it is unlikely that such an HEK293 cell-speci®c factor would be necessary for the formation of recombinant homomeric b subunits since these have also been observed in studies in which Xenopus oocytes were utilized (Sigel et al., 1989; Sanna et al., 1995; Krishek et al., 1996; Cestari et al., 1996) . Additionally, actinomycin D has been used to abolish transcription in oocytes before the injection of b1 cRNA and this did not prevent the expression of functional homomeric receptors .
Currents evoked by propofol and pentobarbitone recorded from HEK293 cells expressing b3 subunits were consistently smaller than were a1b3-mediated currents activated by the IVGAs or GABA (Table 1 ). There are a number of possible explanations for this observation. Homomeric b3 receptors may be less eciently expressed than receptors comprised of a1 and b3 subunits. Alternatively, channels formed by b3 subunits alone may less eectively¯ux Cl 7 than those formed by a1 and b3 subunits together. This could occur either as a result of dierences in the single channel open probabilities (i.e. more frequent or longer openings with a1b3 than b3), or because of a dierence in the conductance of these channels (i.e. larger conductance for a1b3 than b3). A comparison of recordings of single channels formed by homomeric b3 receptors and a1b3 receptors will be required to resolve this issue. However, it is interesting to note that b1 subunits form channels that have similar conductances to those formed when a1 and b1 subunits are expressed together (Blair et al., 1988; Krishek et al., 1996) . This suggests that smaller currents are seen with homomeric b3 receptors in the present study because of less ecient expression, or due to a lower probability of channels opening when the a subunit is absent.
A comparison of our characterization of rat b3 homomeric receptors and previous studies of the properties of b subunits from various species, suggests that there are interesting similarities and important anomalies between the dierent b subtypes, that may in part be species-speci®c. Human and bovine b1 subunits expressed in oocytes form homomeric receptors that can be activated by GABA (Sanna et al., 1995; . By contrast, rodent b1 and murine b2 and b3 homomers cannot be activated by GABA (Sigel et al., 1989; Krishek et al., 1996; Cestari et al., 1996) . Homomeric receptors comprised of rat and human b1 and murine b1 and b3 subunits show spontaneous picrotoxin-sensitive channel openings that are not apparent in recordings from oocytes expressing bovine b1 subunits. In addition, spontaneously active rodent b1 and murine b3 receptors cannot be further activated by GABA, while human b1 homomers can. It is not surprising perhaps that already active rodent b1 and murine b3 receptors cannot be further activated by GABA, and it remains undetermined whether this is caused by a lack of the GABA recognition site. However, rat b3 subunits form GABA-insensitive ion channels that are not spontaneously active and do not bind [
3 H]-muscimol, clearly demonstrating that these homomeric receptors do not have a site for GABA-mediated activation.
Propofol and pentobarbitone elicit currents in oocytes expressing murine and human b1, or murine b3 subunits. This could either be due to potentiation of spontaneous channel openings or direct receptor activation by these IVGAs Cestari et al., 1996) . Pentobarbitone potentiates GABA-activated currents recorded from cells expressing bovine b1 subunits, suggesting that a potentiating site is present on these homomers (Krishek et al., 1996) . Therefore, whether spontaneously active b homomers possess an anaesthetic activation site remains unresolved. However, both propofol and pentobarbitone directly activate quiescent rat b3 homomeric receptors. Thus, sites for activation by these agents are clearly present on this b3 subunit and are distinct from the GABA activation site.
From the binding and the electrophysiological data the modulation of GABA A receptors by propofol and pentobarbitone appears similar. These compounds cause displacement of [ 35 S]-TBPS binding from a1b3 and b3 receptors. They also activate both GABA A receptor combinations and, at higher concentrations, cause surge currents during wash o. The surge currents, seen on cessation of application of pentobarbitone (Peters et al., 1989; Robertson, 1989) and propofol (Orser et al., 1994; Adodra & Hales, 1995) One interpretation of our data, and the results of previous studies (Amin & Weiss, 1993; Sanna et al., 1995; Krishek et al., 1996; Cestari et al., 1996) , is that propofol and pentobarbitone can bind to and activate any combination of GABA A subunits that form receptors in the plasma membrane. At present it is not known whether the binding site is only on the b subunit, or common to many (perhaps all) subunits. The types of subunit may well be unimportant with the exception of their ability to form functional receptors.
A number of previous binding and electrophysiological studies support the notion that anaesthetic steriods act through a dierent site on the GABA A receptor from that of the anaesthetic barbiturates and propofol (Peters et al., 1998; Turner et al., 1989; Hales & Lambert, 1991; Belelli et al., 1996) . [ 3 H]-muscimol binding, maximally enhanced by the barbiturate secobarbitone, can be enhanced further by the addition of the anaesthetic steroid 5b-pregnan-3a-ol-20-one (Peters et al., 1988) . In addition, the anaesthetic steroids dramatically enhance currents activated by high concentrations of anaesthetic barbiturates, suggesting that these agents act at dierent sites on the GABA A receptor complex (Peters et al., 1988; Hales & Lambert, 1991; Belelli et al., 1996) . By contrast, propofol causes only a small enhancement of currents activated by pentobarbitone suggesting that these agents may compete for a similar site of action (Hales & Lambert, 1991) .
Like propofol and pentobarbitone, 5a-pregnan-3a-ol-20-one binds to the b3 subunit leading to the displacement of [
35 S]-TBPS. However, the steroid cannot activate the receptor and has a greatly reduced capacity to potentiate currents activated by propofol. The anaesthetic steriod alphaxalone is also unable to active human b1 homomers directly, but does potentiate GABA-activated currents recorded from the same oocytes (Sanna et al., 1995) . These observations suggest that some b subunits may possess the steriod potentiation site, but lack their site of direct receptor activation.
In summary, our data and the results of previous studies on b subunits suggest that there are some properties common to all subunits of this class that have so far been examined. They form homomeric receptors that are inserted into cell surface membranes. These receptors can be activated by propofol and pentobarbitone, but not by the anaesthetic steroids. There are also surprising dierences between the properties of these receptors even when comparing b subunits of the same subtype between species. For example, murine b3 subunits show spontaneous activity, while those of the rat do not. Also, rodent b1 subunits cannot be activated by GABA, while human and bovine b1 homomers can. By examining the dierences between the sequences of these subunits it may be possible to identify the determinants of these important receptor properties.
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